Table 2 Clinical outcome of IVF treatment of 326 HPV-tested women (27 HPV-positive and 299 HPV-negative).
|  | HPV-positive (n = 27) | HPV-negative (n = 299) | p |
|---|---|---|---|
Total exogenous FSH (IU) | 2491 ± 878 | 2640 ± 998 | 0,409 |
Peak endometrial thickness (mm) | 10.4 ± 2.0 | 10.2 ± 2.0 | 0,677 |
Peak E2 (pg/ml) | 2200 ± 2198 | 1950 ± 1241 | 0,565 |
Retrieved oocytes (n) | 8.5 ± 7.2 | 8.3 ± 5.8 | 0,890 |
Mature (MII) oocytes (%) | 73.5 ± 29.4 | 82.2 ± 18.3 | 0,148 |
Fertilized (2PN) oocytes (%) | 65.6 ± 28.3 | 71.3 ± 24.1 | 0,343 |
Cleaved embryos (%) | 97.8 ± 10.4 | 96.4 ± 12.3 | 0,550 |
Transferred embryos (n) | 33 | 449 | Â |
Implantation rate (%) | 24.2 | 25.8 | 0,840 |
Pregnancy rate/started cycle (%) | 33.3 | 35.8 | 0,799 |
Clinical Pregnancy Rate/started cycle (%) | 29.6 | 33.4 | 0,687 |
Ongoing Pregnancy Rate/started cycle(%) | 22.2 | 28.4 | 0,491 |
Miscarriage rate (%) | 25 | 15 | 0,455 |
Live Birth Rate/started cycle (%) | 22.2 | 28.1 | 0,513 |